Literature DB >> 17923119

Central role of ILT3 in the T suppressor cell cascade.

Nicole Suciu-Foca1, Raffaello Cortesini.   

Abstract

CD8+ T suppressor cells differentiate both in vivo and in vitro upon chronic exposure of responding T cells to allogeneic APC. These Ts are allospecific and exhibit their function interacting directly with priming APC which they render tolerogenic. Tolerogenicity of professional and non-professional human APC, such as dendritic cells and endothelial cells, respectively is due to the upregulation of the inhibitory receptors ILT3 and ILT4. ILT3 signals both intracellularly, inhibiting NF-kappaB activation, and transcription of costimulatory molecules, and extracellularly, inducing anergy and regulatory function in T cells with cognate specificity. Both membrane and soluble ILT3 are proteins with potent immunosuppressive activity which are of importance for treatment of rejection, autoimmunity and cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17923119     DOI: 10.1016/j.cellimm.2007.01.013

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  21 in total

1.  IL-10 enhances promoter activity of ILT4 gene and up-regulates its expression in THP-1 cells.

Authors:  Xiaoli Xu; Ping Zou; Lijuan Chen; Guannan Jin; Hao Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-11-10

2.  Quantification of blood dendritic cells in colorectal cancer patients during the course of disease.

Authors:  Giulia Orsini; Annalisa Legitimo; Alessandra Failli; Paola Ferrari; Andrea Nicolini; Roberto Spisni; Paolo Miccoli; Rita Consolini
Journal:  Pathol Oncol Res       Date:  2013-09-11       Impact factor: 3.201

3.  New concepts in alloimmune recognition.

Authors:  Jeffrey L Platt
Journal:  Cell Immunol       Date:  2007-10-23       Impact factor: 4.868

Review 4.  CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease.

Authors:  Marius Strioga; Vita Pasukoniene; Dainius Characiejus
Journal:  Immunology       Date:  2011-06-29       Impact factor: 7.397

Review 5.  CD8+ Tregs in lupus, autoimmunity, and beyond.

Authors:  Ravi K Dinesh; Brian J Skaggs; Antonio La Cava; Bevra H Hahn; Ram Pyare Singh
Journal:  Autoimmun Rev       Date:  2010-04-10       Impact factor: 9.754

6.  Prostaglandin I2 signaling licenses Treg suppressive function and prevents pathogenic reprogramming.

Authors:  Allison E Norlander; Melissa H Bloodworth; Shinji Toki; Jian Zhang; Weisong Zhou; Kelli Boyd; Vasiliy V Polosukhin; Jacqueline-Yvonne Cephus; Zachary J Ceneviva; Vivek D Gandhi; Nowrin U Chowdhury; Louis-Marie Charbonnier; Lisa M Rogers; Janey Wang; David M Aronoff; Lisa Bastarache; Dawn C Newcomb; Talal A Chatila; R Stokes Peebles
Journal:  J Clin Invest       Date:  2021-04-01       Impact factor: 14.808

Review 7.  Induction of immune tolerance by activation of CD8+ T suppressor/regulatory cells in lupus-prone mice.

Authors:  Brian J Skaggs; Ram Pyare Singh; Bevra H Hahn
Journal:  Hum Immunol       Date:  2008-09-24       Impact factor: 2.850

8.  The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease.

Authors:  M M Harnett; A J Melendez; W Harnett
Journal:  Clin Exp Immunol       Date:  2009-12-01       Impact factor: 4.330

Review 9.  Induction/engineering, detection, selection, and expansion of clinical-grade human antigen-specific CD8 cytotoxic T cell clones for adoptive immunotherapy.

Authors:  Matjaz Jeras; Irena Bricl; Robert Zorec; Urban Svajger
Journal:  J Biomed Biotechnol       Date:  2010-03-10

10.  Expression and function of immunoglobulin-like transcripts on tolerogenic dendritic cells.

Authors:  Juan Wu; Anatolij Horuzsko
Journal:  Hum Immunol       Date:  2009-05       Impact factor: 2.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.